申请人:Sugen, Inc.
公开号:US05891917A1
公开(公告)日:1999-04-06
The present invention relates to molecules capable of modulating tyrosine signal transduction to prevent and treat cell proliferative disorders or cell differentiation disorders associated with particular tyrosine kinases by inhibiting one or more abnormal tyrosine kinase activities.
本发明涉及分子,能够调节酪氨酸信号传导,以通过抑制一个或多个异常酪氨酸激酶活性,来预防和治疗与特定酪氨酸激酶相关的细胞增殖紊乱或细胞分化紊乱。